CS logo
small CS logo
Arlington Center for Dermatology

Arlington, Texas, United States
Dermatologist in Arlington, Texas
711 E Lamar Blvd #200, Arlington, TX 76011

About Arlington Center for Dermatology


"We are so glad you chose Dr. Angela Yen Moore, MD and Arlington Center for Dermatology. If you would like to schedule your first appointment with us, please call us at (817) 795-7546."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Galderma R&D
6
Janssen Research & Development, LLC
5
Astellas Pharma Inc
1
Bristol-Myers Squibb
1
Cipher Pharmaceuticals Inc.
1
Incyte Corporation
1
Janssen Scientific Affairs, LLC
1
LEO Pharma
1
Stiefel, a GSK Company
1
Teva Pharmaceuticals USA
1
Total Rows: 10

Clinical Trials at Arlington Center for Dermatology


During the past decade, Arlington Center for Dermatology conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years22000022330000111111Started TrialsCompleted Trails2018201920202021202201234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris
2006-10-01
2007-12-01
Completed
1,670
Assessment and Tracking of Long-term Alefacept Safety
2003-06-01
2012-02-01
Terminated
1,897
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
2005-05-25
2019-01-31
Terminated
8,071
Psoriasis Longitudinal Assessment and Registry
2007-06-21
2030-12-31
Recruiting
16,000
Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne
2008-10-01
2009-09-01
Completed
1,315
Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne
2009-09-01
2011-05-01
Completed
925
Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea
2010-08-01
2011-01-01
Completed
269
Bioequivalence of Adapalene Topical Gel in Patients With Acne Vulgaris
2007-07-01
2008-04-01
Completed
601

Rows per page:

1–19 of 19

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Arlington Center for Dermatology" #1 sponsor was "Galderma R&D" with 6 trials, followed by "Janssen Research & Development, LLC" with 5 trials sponsored, "Astellas Pharma Inc" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Cipher Pharmaceuticals Inc." with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Arlington Center for Dermatology" #1 collaborator was "GlaxoSmithKline" with 1 trials as a collaborator, "Quintiles, Inc." with 1 trials as a collaborator and "Rho, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading SponsorsGalderma R&D: 6Galderma R&D: 6Janssen Research &Development, LLC: 5Janssen Research &Development, LLC: 5Astellas Pharma Inc: 1Astellas Pharma Inc: 1Bristol-Myers Squibb: 1Bristol-Myers Squibb: 1Cipher Pharmaceuticals Inc.: 1Cipher Pharmaceuticals Inc.: 1Incyte Corporation: 1Incyte Corporation: 1Janssen Scientific Affairs, LLC: 1Janssen Scientific Affairs, LLC: 1LEO Pharma: 1LEO Pharma: 1Stiefel, a GSK Company: 1Stiefel, a GSK Company: 1Teva Pharmaceuticals USA: 1Teva Pharmaceuticals USA: 1

Created with Highcharts 11.1.0Top CollaboratorsGlaxoSmithKline: 1GlaxoSmithKline: 1Quintiles, Inc.: 1Quintiles, Inc.: 1Rho, Inc.: 1Rho, Inc.: 1

Clinical Trials Conditions at Arlington Center for Dermatology


According to Clinical.Site data, the most researched conditions in "Arlington Center for Dermatology" are "Acne Vulgaris" (5 trials), "Psoriasis" (4 trials), "Rosacea" (3 trials), "Plaque Psoriasis" (2 trials) and "Atopic Dermatitis" (1 trials). Many other conditions were trialed in "Arlington Center for Dermatology" in a lesser frequency.

Clinical Trials Intervention Types at Arlington Center for Dermatology


Most popular intervention types in "Arlington Center for Dermatology" are "Drug" (17 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Adapalene" (2 trials), "Bermekimab" (2 trials), "Guselkumab" (2 trials) and "Vehicle cream" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Arlington Center for Dermatology


The vast majority of trials in "Arlington Center for Dermatology" are 19 trials for "All" genders.

Clinical Trials Status at Arlington Center for Dermatology


Currently, there are NaN active trials in "Arlington Center for Dermatology". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Arlington Center for Dermatology, undefined suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Arlington Center for Dermatology, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 8Phase 3: 8Phase 2: 7Phase 2: 7Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 10Completed: 10Recruiting: 4Recruiting: 4Terminated: 4Terminated: 4Active, not recruiting: 1Active, not recruiting: 1